Published in Clinicoecon Outcomes Res on September 23, 2013
Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014. PLoS One (2016) 2.50
Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles. PLoS One (2015) 0.87
Cardiovascular disease risk in an aging HIV population: not just a question of biology. Curr Opin HIV AIDS (2014) 0.82
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Ther (2017) 0.80
Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors: Toward a New Practice of Global Health Cardiology. Cardiol Clin (2017) 0.75
A population-based study of care at the end of life among people with HIV in Ontario from 2010 to 2013. J Acquir Immune Defic Syndr (2016) 0.75
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population. BMC Public Health (2016) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21
Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med (1998) 7.12
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med (2006) 5.49
Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Public Health Rep (1987) 4.98
Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis (2011) 4.79
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (2009) 4.19
Medical care costs of patients with AIDS in San Francisco. JAMA (1986) 3.85
Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis (2006) 3.72
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med (2001) 3.64
The role of HIV in serious diseases other than AIDS. AIDS (2008) 3.39
The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med (2004) 3.07
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep (2010) 2.97
Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS (1999) 2.73
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med (2009) 2.30
Contemporary costs of HIV healthcare in the HAART era. AIDS (2010) 2.16
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
Impact of combination therapy for HIV infection on inpatient census. N Engl J Med (1997) 1.99
HIV infection in older patients in the HAART era. J Antimicrob Chemother (2005) 1.90
The direct costs of HIV/AIDS care. Lancet Infect Dis (2006) 1.87
Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc (2009) 1.79
Aging, disability and frailty. Ann Nutr Metab (2008) 1.74
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
HIV infection in older adults. Clin Geriatr Med (2007) 1.62
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol (2005) 1.61
Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation (1996) 1.58
Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care (2010) 1.55
Determinants of long-term care spending: age, time to death or disability? J Health Econ (2011) 1.34
Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS (1999) 1.33
Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006. HIV Med (2008) 1.30
Prioritizing primary care in HIV: comorbidity, toxicity, and demography. Top HIV Med (2007) 1.17
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002). Int J STD AIDS (2008) 1.04
The evolving burden of HIV infection compared with other chronic diseases in northern Italy. HIV Med (2011) 0.97
Rising population cost for treating people living with HIV in the UK, 1997-2013. PLoS One (2010) 0.96
Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer. J Natl Cancer Inst (2000) 0.91
Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART. AIDS Rev (2009) 0.88
Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer--is it cost-effective? Acta Oncol (2000) 0.81
Analysis of costs by CD4 count category for the darunavir/r 600/100 mg bid and control protease inhibitor arms of the POWER 1 and 2 trials. HIV Clin Trials (2007) 0.78
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst (2005) 9.10
Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis (2011) 4.79
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol (2003) 4.10
Impact of HIV infection and HAART on serum lipids in men. JAMA (2003) 4.01
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol (2009) 3.57
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2004) 3.54
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol (2005) 2.95
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC. J Clin Oncol (2003) 2.65
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med (2003) 2.61
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial. J Clin Oncol (2007) 2.48
Massive pulmonary embolism. Circulation (2006) 2.27
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Clin Infect Dis (2008) 2.06
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS (2004) 1.82
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol (2007) 1.80
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med (2005) 1.76
Drug utilisation profile in the Italian paediatric population. Eur J Pediatr (2008) 1.67
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging (2011) 1.63
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis (2006) 1.61
Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS (2011) 1.55
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS (2011) 1.53
The pathology of gastric cardia: a prospective, endoscopic, and morphologic study. Am J Surg Pathol (2007) 1.48
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS (2011) 1.42
Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up. Plast Reconstr Surg (2012) 1.40
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol (2006) 1.40
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). J Thorac Oncol (2007) 1.25
Renal disease in HIV-infected individuals. Curr Opin HIV AIDS (2011) 1.15
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis (2009) 1.14
Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2008) 1.14
Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg (2007) 1.12
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol (2009) 1.10
Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol (2003) 1.10
Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis (2007) 1.09
Severity of lipodystrophy is associated with decreased health-related quality of life. AIDS Patient Care STDS (2008) 1.06
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS (2009) 1.04
Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS One (2011) 0.98
Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus. Hum Pathol (2008) 0.98
Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev (2008) 0.97
Detectable HIV viral load is associated with metabolic syndrome. J Acquir Immune Defic Syndr (2009) 0.97
Systematic review of piperacillin-induced neutropenia. Drug Saf (2007) 0.97
Antidiabetic therapy in real practice: indicators for adherence and treatment cost. Patient Prefer Adherence (2012) 0.96
Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther (2007) 0.95
Ectopic fat is linked to prior cardiovascular events in men with HIV. J Acquir Immune Defic Syndr (2012) 0.95
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy. HIV Clin Trials (2006) 0.95
Immunophenotypic alterations in acute and early HIV infection. Clin Immunol (2007) 0.94
Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr (2006) 0.94
Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clin Trials (2003) 0.94
Enteric glial cells and their role in gastrointestinal motor abnormalities: introducing the neuro-gliopathies. World J Gastroenterol (2007) 0.94
Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol (2004) 0.93
Laparoscopic cholecystectomy with Harmonic scalpel. JSLS (2010) 0.93
Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study. PLoS One (2011) 0.93
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. Antivir Ther (2009) 0.92
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS (2015) 0.92
Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy. J Acquir Immune Defic Syndr (2014) 0.91
Overexpression of mammaglobin B in epithelial ovarian carcinomas. Gynecol Oncol (2007) 0.91
Quality of diabetes care in Italy: information from a large population-based multiregional observatory (ARNO diabetes). Diabetes Care (2012) 0.88
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther (2005) 0.87
Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity. Anticancer Res (2008) 0.87
Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV. Am Heart J (2012) 0.86
Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy. Clin Infect Dis (2008) 0.86
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients. J Acquir Immune Defic Syndr (2013) 0.86
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. Antivir Ther (2012) 0.86